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Abstract
BACKGROUND: Metabolic resistance is an important consideration in the whiteﬂy Bemisia tabaci, where an esterase-based
mechanism has been attributed to pyrethroid resistance and over-expression of the cytochrome P450, CYP6CM1, has been
correlated to resistance to imidacloprid and other neonicotinoids.
RESULTS: In vitro interactions between putative synergists and CYP6CM1, B and Q-type esterases were investigated, and
structure–activity relationship analyses allowed the identiﬁcation of chemical structures capable of acting as inhibitors of
esterase and oxidase activities. Speciﬁcally, methylenedioxyphenyl (MDP) moieties with a polyether chain were preferable
for optimum inhibition of B-type esterase, whilst corresponding dihydrobenzofuran structures were potent for the Q-esterase
variation.Potent inhibitionofCYP6CM1resulted fromstructureswhichcontainedanalkynyl chainwitha terminalmethylgroup.
CONCLUSIONS: Synergist candidates could be considered for ﬁeld control of B. tabaci, especially to abrogate neonicotinoid
resistance.
© 2017 Society of Chemical Industry
Supporting informationmay be found in the online version of this article.
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1 INTRODUCTION
The whiteﬂy Bemisia tabaci (Gennadius) (Hemiptera: Aleyrodidae)
is a globally important pest of agricultural and ornamental crops,
with a host range of more than 900 plants, capable of causing
damage to the leaves by direct feeding or honeydew contamina-
tion, and also by transmitting many plant virus species.1 Among
the wide range of biotypes reported, type ’B’ (also known as
‘Middle East–Asia’) and type ‘Q’ (also known as ‘Mediterranean
species’) represent the two major groups which have shown an
ability to develop resistance to diﬀerent insecticide classes used
extensively for their control.2
Numerous reports from diﬀerent parts of the world docu-
ment thewidespread occurrence of resistantwhiteﬂy populations,
mainly correlated to enhanced levels of phase I enzymes: esterases
and oxidases.3–8
Pyrethroid, organophosphate (OP) and carbamate resistance
has been attributed to an esterase-based resistance mechanism.
The over-produced esterases are responsible for the cleavage or
sequestration of these insecticides, thus preventingmodulation of
the voltage gated sodium channel or the irreversible inhibition of
the acetylcholinesterase enzyme.3,5,6
Neonicotinoid insecticides with a diﬀerent mode of action
(they are selective agonists of nicotinic acetylcholine receptors)
were introduced against numerous pests, including B. tabaci,
had the considerable advantage of being less-aﬀected by the
existing resistance mechanisms of the previously mentioned
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insecticides. Nevertheless, their extensive use to control resis-
tant populations culminated in a decreased susceptibility of the
whiteﬂies. The ﬁrst report of neonicotinoid resistance was docu-
mented in a Spanish greenhouse population, showing a reduced
eﬃcacy of imidacloprid4 and possible cross-resistance between a
neonicotinoid insecticide (acetamiprid) and thiamethoxam was
demonstrated.9 Since then, cases of loss of eﬃcacy were docu-
mented in diﬀerent parts of Europe and correlated to enhanced
levels of microsomalmonooxygenases.7,10 One single cytochrome
P450 enzyme (CYP6CM1)was found tobehighly over-expressed in
imidacloprid resistant populations of bothB- andQ-typeB. tabaci.8
Furthermore, laboratory studies performed with the recombinant
form of the Q-biotype version of the enzyme (CYP6CM1vQ)
showed the capability to cross-metabolise other neonicotinoid
molecules like clothianidin and thiacloprid.11
Piperonyl butoxide (PBO) has been used for many years to aid
diagnosis of oxidase-modulated resistance through inhibition of
cytochrome P450 enzymes in household pests including Cimex
letularius,12 Blatella germanica,13 disease vectors such as Culex
quinquefasciatus,14 and agriculturally important pests including
Plutella xylostella15 and Pseudoplusia includens,16 reviewed by
Glynne-Jones.17 More recently, it has been shown that PBO also
inhibits resistance-associated esterases,18,19 and thus it should
be considered as a diagnosis to metabolic resistance rather than
speciﬁcally diagnosing enhanced P450 activity.
Many in vitro studies showed that there was a decreased P450
activity in microsomal fractions from insects treated with MDP
compounds20 and with PBO and NADPH.21,22 On this basis it was
suggested that MDP compounds form metabolic intermediates
(MIs) preventing enzymatic activity.23 The molecular mechanism
bywhichPBO in thepresenceofNADPH interactswith cytochrome
P450s is classically referred to as mechanistic (a suicide substrate),
following the formation of an intermediate carbene moiety.
In order to detect the involvement ofmetabolic resistancemech-
anisms, PBO has previously been used in laboratory bioassays and
ﬁeld trials against resistant whiteﬂy populations, conﬁrming the
importance of detoxifying enzymatic pathways in the analysed
insects.10,12–14
This work aimed to better explore/abrogate metabolic resis-
tance mediated by enhanced levels of the previously mentioned
enzymes of the cotton whiteﬂy B. tabaci, through the investiga-
tion of possible interactionswith awide range of putative PBO-like
inhibitors.
2 MATERIALS ANDMETHODS
2.1 Whiteﬂies
The B-type resistant strain was a long term frozen (−80 ∘C) popu-
lation originally collected from Cyprus in 2003. Adult Q-type resis-
tant whiteﬂies were collected from ornamental plants kept in a
greenhouse in Savona district (Liguria, Italy) in 2013 and main-
tained on tobacco plants, at a constant temperature of 26 ∘C and a
16:8 h light:dark photoperiod.
2.2 Chemicals
Technical PBO and analogues with modiﬁcations in the
methylenedioxyphenyl (MDP) moiety, alkyl and polyether side
chains were supplied by Endura SpA (Bologna, Italy) (Table 1).
Derivatives 7, 11, 12, 25, 40 were synthesised according to
the chemical process reported in Bertok et al.24 Derivatives
18, 19, 20, 21, 22, 24, and 43 were synthesised according
to Borzatta et al.25 Compound 10 was synthesised accord-
ing to Moore and Hewlett.26 Derivative 23 was synthesised
according to Fellig and Rachlin.27 Derivatives 41 and 42 were
synthesised by enantioselective reduction of the corresponding
acetyl dimethoxybenzene by using [RuCl2(p-cymene)]complexed
with (1R,2R)-(−)N-p-tosyl-1,2-diphenylethylenediamine) and
(S,S)-(−)N-p-tosyl-1,2-diphenylethylenediamine) and further
condensation with 2-butyn-1-ol. Derivatives 13, 14, 15, 16,
17, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38 and 39
were synthesised following the synthesis procedures reported
in Philippou et al.28 Derivative 9 was synthesised according to
Moores et al.29 Derivatives 8 and 13 were synthesised accord-
ing to Arvai et al.30 Benzodioxole and benzodioxane derivatives,
2, 3, 4, 5, 6 and 44, were synthesised following the synthesis
procedure reported in Ugolini et al.31 Benzodioxole derivative
45 was synthesised according to Tozzi.32 Dimethoxybenzene
derivative was synthesised following the procedure reported
in Panini et al.33
All thederivativeswerepuriﬁedbyusing the suitablepuriﬁcation
techniques such as distillation, crystallisation and column chro-
matography. The physico-chemical characteristics and NMR anal-
yses of the novel compounds are reported in the supporting infor-
mation.
2.3 Baculovirus-mediated CYP6CM1 expression
Full-length B. tabaciCYP6CM1 sequence (GenBank accession num-
ber GQ214539) and Drosophila melanogaster NADPH cytochrome
P450 reductase (CPR) sequence (GenBank accession number
Q27597) were obtained as described in Nauen et al.,34 but using
High 5 (Trichoplusa ni) cells in place of Sf9 for reduced background
activity against model substrates. Expression of P450 was checked
by measuring CO-diﬀerence spectra in reduced samples35 and
enzymatic activity checked with ﬂuorescence substrates. Aliquots
of recombinant CYP6CM1 were stored at −80 ∘C.
2.4 Inhibition of P450 activity
Inhibition of recombinant CYP6CM1 enzyme was measured as
described by Moores et al.36 Brieﬂy, 7-ethoxycoumarin (7-EC) was
dissolved in ethanol tomake a 20mM stock solution and diluted to
0.125mMby the addition of 0.1 M sodiumphosphate buﬀer, pH 7.8.
Aliquots of the diluted recombinant enzyme (50 μL, 0.5 pmol)were
dispensed into a 96-well microplate (OptiplateTM, white; Perkin
Elmer, Seer Green, Beaconsﬁeld, UK).
In a preliminary experiment, 3 μL of three analogues (structures
1, 14 and 18; stock 10mM in acetone) possessing the MDPmoiety
were incubated for 10min (condition 1) or 30min (condition 2) in
the presence of 10 μL of 9.6mMNADPH. After the incubation, 80 μL
of 0.125mM 7-EC were added, followed by 10 μL of 0.1 M sodium
phosphate, pH 7.8.
In parallel, 3 μL of the same analogueswere incubated for 10min
(condition 3) or 30min (condition 4) in the absence of NADPH,
replaced by 10 μL of 0.1 M sodium phosphate, pH 7.8. After the
incubation, 80 μL of 0.125mM 7-EC were added, followed by 10 μL
9.6mM NADPH.
For all conditions, two negative controls containing cytochrome
P450 reductase (CPR) only, or the absence of 7-EC, were included.
The reaction was monitored using a Spectramax Gemini EM
(Molecular Devices, Menlo Park, CA, USA) for 60min, with readings
taken every min, using an excitation wavelength of 390 nm and
an emission wavelength of 460 nm, with a 435 nm cut-oﬀ ﬁlter.
O-Deethylation activity was calculated as the rate of production
wileyonlinelibrary.com/journal/ps © 2017 Society of Chemical Industry Pest Manag Sci 2017; 73: 1873–1882
1875
Interactions between synergists and phase 1 enzymes of B. tabaci www.soci.org
Table 1. Structures of PBO analogues
A B C D  
E F                        G
Structure number Name Aromatic ring R1 R2
1 PBO A CH2CH2CH3 (CH2OCH2)3CH2CH2CH3
2 EN 1-14 A CH2CH2CH2CH3 (CH2OCH2)3CH2CH2CH3
3 EN 1-16 A CH2CH2CH2CH2CH2CH3 (CH2OCH2)3CH2CH2CH3
4 EN 1-40 A H (CH2OCH2)3CH2CH2CH3
5 EN 1-42 A (CH2OCH2)3CH2CH2CH3 (CH2OCH2)3CH2CH2CH3
6 EN 1-48 A CH2CH2CH3 (CH2OCH2)2C6H6
7 EN 1-93 A CH2CH2CH3 COOH
8 EN 1-125 A H CH2OCH2C≡CCH3
9 EN 1-126 A CH2CH2CH3 CH2OCH2C≡CCH3
10 EN 1-129 A H (CH2)11CH3
11 EN 1-162 A CH2CH2CH3 (CH2OCH2)3COONa
12 EN 1-182 A H CH2CH(CH3)CH2OCH2C≡CCH3
13 EN 1-198 A CH2CH2CH3 CH2OCH2C≡CH
14 EN 1-213 A CH2CH2CH2CH2CH2CH3 CH2OCH2C≡CCH3
15 EN 1-215 A CH2CH2CH2CH3 CH2OCH2C≡CCH3
16 EN 1-216 A CH2CH2CH2CH3 CH2OCH2C≡CH
17 EN 1-218 A CH2CH2CH2CH2CH2CH3 CH2OCH2C≡CH
18 EN 1- 163 B H CH2C≡CCH3
19 EN 1-164 B CH2CH2CH3 CH2C≡CCH3
20 EN 1-175 B H (CH2CH2O)2CH2CH2CH2CH3
21 EN 1-179 B OCH2C≡CCH3 (CH2CH2O)2CH2CH2CH2CH3
22 EN 1-180 B CH2CH2CH3 (CH2CH2O)2CH2CH2CH2CH3
23 EN 1-181 B H CH2C≡CH
24 EN 1-183 B CH2CH2CH3 CH2C≡CH
25 EN 1-186 B CH2CH2CH3 CH2CH2OCH3
26 EN 16-06 C (CH2OCH2)3CH2CH2CH3 H
27 EN 16-18 C OCH2C≡ CCH3 H
28 EN 16-55 C CH2CH2CH3 (CH2OCH2)3CH2CH2CH3
29 EN 16-56 C CH2CH2CH3 OCH2C≡ CCH3
30 EN 16-28 C CH2CH2CH2CH2CH2CH3 (CH2OCH2)3CH2CH2CH3
31 EN 16-39 C CH2CH2CH2CH2CH2CH3 CH2OCH2C≡CH
32 EN 16-40 C CH2CH2CH2CH2CH2CH3 CH2OCH2C≡CCH3
33 EN 16-41 C CH2CH2CH2CH3 CH2OCH2C≡CCH3
34 EN 16-42 C CH2CH2CH2CH2CH2CH3 OCH2C≡CCH3
35 EN 16-43 C CH2CH2CH2CH3 CH2OCH2C≡CH
36 EN 16-44 C CH2CH2CH2CH2CH2CH3 OCH2C≡CH
37 EN 16-46 C CH2CH2CH3 CH2OCH2C≡CCH3
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Table 1. continued
A B C D  
E F                        G
Structure number Name Aromatic ring R1 R2
38 EN 16-47 C CH2CH2CH3 CH2OCH2C≡CH
39 EN 14-05 D CH2CH2CH3 (CH2OCH2)3CH2CH2CH3
40 EN 25-08 E H CH(CH3)OCH2C≡ CCH3 (RS)
41 EN 25-09 E H CH(CH3)OCH2C≡ CCH3 (S)
42 EN 25-10 E H CH(CH3)OCH2C≡ CCH3 (R)
43 EN 25-37 E H OCH2C≡ CCH3
44 EN 18-05 F CH2CH2CH3 (CH2OCH2)3CH2CH2CH3
45 EN 1-44 G (CH2OCH2)3CH2CH2CH3 (CH2OCH2)3CH2CH2CH3
In structure 45, R3 is (CH2OCH2)3CH2CH2CH3 .
of 7-hydroxycoumarin and expressed as ﬂuorometric units per
minute (FU min−1), using the integrated software programme
Softmax Pro version 5.4 to ﬁt the linear regressions. All assays were
repeated in triplicate.
Inhibition of CYP6CM1 by analogues was then performed as per
the latter method above (condition 4).
2.5 Esterase puriﬁcation
Since many resistance-associated esterases in insect pests are
known to be glycosylated, the decision was made to purify
the resistance-characterised esterases from B. tabaci, rather
than make recombinant versions. Esterases (B and Q) were
semi-puriﬁed from whiteﬂy samples using size exclusion and ion
exchange chromatography. Whiteﬂies were bulk homogenised
on ice in 5mL of 0.02 M phosphate buﬀer pH 7.0 and centrifuged
at 10 000× g for 5min. The supernatant was passed through
a Sephadex G-25 column (Fine) (Amersham Biosciences, Little
Chalfont, Bucks, UK) (2 cm diameter× 10 cm height) to separate
low molecular weight material. The proteins were eluted using
0.02 M Tris–HCl buﬀer pH 8.5. Unretarded fractions were collected,
loaded onto an ion exchange column (DEAE Sepharose TM Fast
Flow) (Amersham Biosciences) (2.5 cm diameter× 6 cm height)
and eluted using a linear 0–0.35 M NaCl gradient in 250mL of
Tris–HCl pH 8.5.
Fractions (2mL) were collected and tested for total esterase
activity using a colorimetric assay with 1mM (ﬁnal) 4-nitrophenyl
acetate as substrate. The assay was performed in a Tmax kinetic
microplate reader (Molecular Devices, Menlo Park, CA, USA) tak-
ing readings every 20 s at 405 nm for 5min. The integrated soft-
ware programme Softmax Pro version 5.4 was used to ﬁt linear
regressions, the slopes of which were summarised as a rate of
milli-optical density changeperminute at 405 nm (mOD405 min
−1).
Fractions with the highest activities were pooled and passed
through a Sephadex G-25 column (Fine; Amersham Biosciences)
to desalt and buﬀer exchange to 0.02 M phosphate buﬀer pH 7.0
for storage. Aliquots were frozen at −20 ∘C.
2.6 Inhibition of esterase activity
Inhibition of esterase activity was measured using 4-nitrophenyl
octanoate (pNO). Stocks (10mM) of the substrate were prepared
in acetone and diluted to 2mM by the addition of 0.02 M phos-
phate buﬀer pH 7.0. Aliquots of the puriﬁed enzyme (50 μL) was
dispensed into a 96-well microplate (maxisorb; NUNC, VWR Inter-
national, Magna Park, Lutterworth, UK), in addition to 100 μL
0.02 M phosphate buﬀer pH 7.0, mixed with 2.5 μL of inhibitor
(stock 10mM in acetone) and incubated for 10min at room tem-
perature. Acetone only was used as uninhibited control. After the
incubation, 100 μL of 2mM pNO was added, and esterase activity
monitored at 405 nm in a Spectramax Tmax kinetic microplate,
taking readings every 5 s for 5min. The integrated software
programme Softmax Pro version 5.4 was used to ﬁt linear regres-
sions. The slopes were recorded as a rate of milli optical density
wileyonlinelibrary.com/journal/ps © 2017 Society of Chemical Industry Pest Manag Sci 2017; 73: 1873–1882
1877
Interactions between synergists and phase 1 enzymes of B. tabaci www.soci.org
change per minute at 405 nm (mOD405 min
−1). All assays were
repeated in triplicate.
2.7 Homologymodelling andmolecular docking
The crystal structure of human liver P450, CYP3A4 (PDB entry
1TQN),37 was used as a template for the protein model of
CYP6CM1. Docking of PBO and selected analogueswas carried out
usingAutodockVinaon the constructedenzymemodel.38 Thepro-
teinhydrogenatoms, atomcharges and solvationparameterswere
added to the model using Auto Dock Tools (version 1.5.4).39 Grid
boxes were generated to encompass the whole proteins. Docking
simulations were performed with an ‘exhaustiveness’ of 200.
3 RESULTS
3.1 CYP6CM1 inhibition by PBO and analogues
Results of the preliminary assays (Table 2) showed that
‘pre-activation’ of the MDP moiety by NADPH (conditions 1
and 2) resulted in equal inhibition to ‘co-activation’ (conditions 3
and 4). It also conﬁrmed that a longer incubation time (conditions
2 and 4) did not result in increased inhibition, as found previously
with B. tabaci preparations.36
Results in Fig. 1A show the diﬀerence in the ability of the ana-
logues to inhibit CYP6CM1 O-deethylation activity. The most
eﬀective compounds contained a triple bond located within the
chain (8, 21, 29, 33); removal of the terminal methyl group from
the alkynyl moiety resulted in lower inhibition (15>16; 14>17;
32> 31; 33> 35). Among the alkynyl structures, no consistent
increase/decrease in potency was observed following removal
of an oxygen from the MDP ring (15>33; 13> 38; 16> 35 but
14< 32; 24< 29). The presence/absence of the methylene bridge
seemed to be unimportant (35<36; 8< 18 but 32> 34; 9>19),
whilst the presence of a butyl side chain was better than hexyl
(15> 14; 16>17).
PBO-like structures (those with a polyether chain) were less
eﬀective than the corresponding alkynyl analogues (2<15;
20< 21; 30< 32). The absence of a methylene bridge to gener-
ate a sesamol structure improved the potency of the analogues
(22> PBO), as did the removal of one oxygen from the MDP ring
(28> PBO) and the absence of the alkyl chain (no chain: 4>butyl:
2/propyl: PBO/hexyl: 3).
Structures that are electron-donating on both chains showed
good inhibition (21, 5); particularly, analogue 21 carrying both a
polyether chain and an alkynyl chain which resulted in one of the
most potent CYP6CM1 inhibitors.
In general, the most eﬀective structures contained an alkynyl
chain with a terminal methyl group, whilst PBO-like structures did
not perform well, giving very low inhibition at this concentration.
3.2 B-type esterase inhibition by PBO and analogues
Results in Fig. 1B show the diﬀerent ability of the analogues to
blockade esterases from the B-type strain. In MDP derivatives
increasing the length of the alkyl chain was unimportant, as there
were no diﬀerences in inhibition with structures having a propyl,
butyl or hexyl (PBO= 2=3; 13= 16=17). However, the loss of the
alkyl chain resulted in a consistent decrease in inhibition, not only
in MDP derivatives (PBO> 4; 9>8) but also in sesamol derivatives
(22> 20; 19>18; 24>23).
In structures with the polyether chain, the introduction of a
second polyether chain partially restored the ability to inhibit
esterase activity (5>4); the substitution of this second chain with
Table 2. Comparison of CYP6CM1 activity remaining (%) after incu-
bation with (1 and 2) or without (3 and 4) NADPH, followed by incuba-
tion with 7-EC and NADPH
Condition Structure 18 Structure 14 Structure 1
1 31.0 44.3 93.3
2 36.2 47.3 87.2
3 34.9 46.7 89.4
4 37.7 49.6 91
Condition 1: 10min pre-incubation of MDP and NADPH with
CYP6CM1; Condition 2: 30min pre-incubation of MDP and NADPH
with CYP6CM1. Condition 3: preincubation without NADPH, 10min
incubation with CYP6CM1; Condition 4: preincubation without
NADPH, 30min incubation with CYP6CM1. Full details are given in the
methods.
an alkynyl ether chain fully restored the eﬃcacy (21> 4). The
presence of a sodium carboxylate (—COONa) group at the end of
the polyether chain (11), or a shorter polyether chain (25), or the
replacement of the polyether chain with a dodecyl chain (10) or a
carboxyl group (7) resulted in a signiﬁcant reduction of inhibition,
as did replacement with a butynyloxy chain when compared to its
polyether counterpart (8< 4; 9< PBO).
Removal of one oxygen from the MDP moiety showed a small
decrease of inhibitory potency of the structures if an alkyl chain
was present (29<19; 28< PBO), as did removal of both the
oxygen atoms (39< PBO). If a single oxygen atom was retained in
the absence of an alkyl chain, change in potency was dependent
upon the presence of a polyether chain (26> 4) or alkynyl moiety
(27< 18).
Considering the alkynyl structures, dihydrobenzofuran moieties
were more eﬀective in some cases (32> 14; 31> 17), but not in
others (33=15; 38< 13). Removal of the terminal methyl had
negative eﬀects for both MDP (23< 18; 24< 19; 16= 15) and
dihydrobenzofuran moieties (35< 33; 38< 37; 31=32).
Removal of the methylene bridge and changing from a MDP
to a sesamol structure produced contrasting results, showing
no diﬀerences in polyether derivatives (4=20; PBO=22) nor
for MDP alkynyl structures (31= 36; 32=34), but increasing
the eﬃcacy in the case of dihydrobenzofuran alkynyl moieties
(8< 18; 9< 19).
In general, ‘PBO-like’ structures were more potent than alkynyl
phenoxy structures, demonstrated by the presence of only a single
alkynyl compound among the 10 most potent inhibitors. This is
clearly conﬁrmed by the comparison between PBO and 13, where
replacement of the polyether chainwith the alkynyl chain resulted
in lower inhibition.
3.3 Q-type esterase inhibition by PBO and analogues
Results in Fig. 1C show thediﬀerence in the ability of the analogues
to blockade esterases from the Q-type strain. In MDP structures
containing a polyether chain, a butyl alkyl chain (2) seemed to
perform slightly better than the propyl or the hexyl (PBO or
3), whilst there was a consistent decrease of inhibitory potency
when the alkyl chain was removed (4< PBO; 20< 22). This was
not always true when an alkynyl moiety was present, where
the absence of the alkyl chain increased the eﬃcacy (18> 19)
but decreased in others (8< 9), perhaps due to the presence of
the methylene bridge. Among dihydrobenzofuran moieties with
alkynyl chain, again a butyl alkyl chain seemed to perform better
than a propyl or hexyl chain (butyl: 33>propyl: 37> hexyl: 32).
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Figure 1. Activity remaining (%) calculated for diﬀerent analogues, including PBO (black columns). (A) CYP6CM1; (B) B-esterase; (C) Q-esterase. Activity
remaining was calculated as a percentage of uninhibited activity (not shown). The best performing analogue is reported in white.
The introduction of an alkynyl ether chain in structures with a
polyether chain improved eﬃcacy (21> 4), and enhancementwas
also obtained with a second polyether chain (5>4), performing
similar to PBO. The presence of a sodium carboxylate (—COONa)
group at the end of the polyether chain (11) and replacement of
the side chain with a carboxyl group (7) or with a dodecyl chain
(10) showed low inhibitory potency, as did structure 25 with a
shortened polyether chain and a propyl side chain. Also, replace-
ment of the polyether chain with a butynyloxy chain reduced
the inhibition potency when compared to its counterpart (8<4;
9< PBO).
Removal of one oxygen from the MDPmoiety resulted in higher
inhibition potency of the structures (28> PBO; 29> 19), whilst
structure 39, with no oxygen in the ring, performed worse than
wileyonlinelibrary.com/journal/ps © 2017 Society of Chemical Industry Pest Manag Sci 2017; 73: 1873–1882
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PBO. The maintenance of only one oxygen atom in the absence
of an alkyl chain and only a polyether chain in the para position
negatively aﬀected the inhibition rates for structures with alkynyl
chain (27<18 but 26> 4).
Removal of the methylene bridge and changing from a MDP
to a sesamol structure produced lower aﬃnity (4> 20; PBO>22;
9> 19) unless superimposed on an alkynyl structure lacking an
alkyl chain (8< 18).
Alkynyl moieties showed higher potency with a dihydrobenzo-
furan moiety replacing the MDP ring, particularly if the terminal
methyl group was present (33>15; 32> 14), but this was not
always true if the terminal methyl group was absent (35>16;
31> 17 but 38< 13). Modiﬁcation of the alkynyl moiety by
removal of the terminal methyl group showed similar (24>19) or
decreased binding aﬃnities (23<18); decreased inhibition poten-
cies were detected for dihydrobenzofuran structures with shorter
alkyl chains (hexyl: 31<32; butyl: 35<33; propyl: 38<37).
In general, structures with a polyether chain, expecially with
dihydrobenzofuran moieties, were more eﬀective than alkynyl
phenoxy equivalents, provided that the alkyl chain length was
shorter than hexyl.
3.4 Bi-variate analysis
Results from all the inhibition assays are summarised in Fig. 2A and
B. In general, no clear correlations between oxidase and esterase
inhibitionwere observed, for either B- or Q-typewhiteﬂies. Several
analogues were found to be potent inhibitors of CYP6CM1 at
the diagnostic concentration, unlike PBO, which gave only 10%
inhibition. Abi-variate plot betweenCYP6CM1andB-type esterase
highlighted structure 21 (analogue EN 1–179) as the most potent
inhibitor of the two enzymes (Fig. 2A). A bi-variate plot between
CYP6CM1 and Q-type esterase highlighted both structures 21
and 33 (analogue EN 16–41) as the optimum analogues, with no
signiﬁcant diﬀerence between them (Fig. 2B).
3.5 Proteinmodelling of interactions
Representations of thepredicteddockingpositions and conforma-
tions of PBO and analogues with CYP6CM1 are shown in Fig. 3 and
Fig. 4.
Both PBO and analogue 21 (structure EN 1–179) are held in
position by aromatic interactions with Phe-501, Phe-64 and pos-
sibly Pro-117; analogue 21 is further stabilised by hydrogen bonds
which are predicted to occur with Arg-224 and Phe-501 (Fig. 3A
and B). The former residue has already been shown to be involved
in interactions between imidacloprid and the biotype Q variant of
the CYP6CM1 enzyme (CYP6CM1vQ).40 The docking energies for
CYP6CM1 and PBO was calculated to be −7.4 Kcal mol−1 and −7.5
Kcal mol−1 respectively.
The docking energies for CYP6CM1 and analogue 15 (structure
EN 1–215) was calculated to be −8.0 Kcal mol−1 and −7.9 Kcal
mol−1 for PBO and analogue 33 (structure EN 16–41) respectively.
The analogues are both held in position by aromatic interactions
with Pro-117, Phe-501 and Phe-64, and further anchorage is pro-
vided by a hydrogen bond to Lys-412 (Fig. 4). The oxygens on
the MDP moiety of EN 1–215 do not, therefore, enter into bind-
ing directly, and the dihydrobenzofuran equivalent is in the same
docking position.
4 DISCUSSION
Insecticide resistance continues to be amajor concern for the con-
trol of agricultural insect pests; a problem that is exacerbated by
Figure2.Bi-variate plots summarising the inhibition against CYP6CM1and
B-esterase (A) or Q-esterase (B). PBO (structure number 1, black circle) and
analogues EN 1–179 (structure number 21, white square) and EN 16–41
(structure number 33, black square) are indicated.
the phasing out of several active ingredients. One possible solu-
tion would be the optimisation of permitted compounds by the
addition of a synergist that inhibits the action of hyper-expressed
metabolic enzymes in resistant populations.
The work described here explores the interactions between
detoxifying enzymes of the whiteﬂy B. tabaci and PBO analogues
designed against the metabolic enzymes of another important
agricultural pest, the green peach aphidMyzus persicae.33
Previous ﬁndings demonstrated that PBO-pyrethroid applica-
tions may enhance the insecticide eﬃcacy in resistant popula-
tions of B-type B. tabaci, following the inhibition of pyrethroid
resistance-associated esterases.41 The eﬀect is more evident if PBO
is applied before the insecticide, allowing a reduction of the insec-
ticidal dose to be applied, as demonstrated with small-scale ﬁeld
trials performed by the same authors. Starting from these obser-
vations, a selection of PBO analogues were explored, looking for
morepotent inhibitors on thebasis of speciﬁc interactionswith the
enzymatic structures of both B- and Q-type esterases.
Inhibition of esterase activities were detected through the assay
with pNO using the semi-puriﬁed enzymes, without requiring the
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Arg 224
Phe 501
Phe 64
Pro 117
Leu 234
Lys 412
Arg 224
Phe 64
Phe 501
Pro 117
Leu 234
Lys 412
(B)
(A)
Figure 3. In silico model of PBO (A) and EN 1–179 (B) docked with
CYP6CM1. Hydrogen bonds (dotted lines) between EN 1–179 and Arg-224
and Phe-501 are shown.
production of recombinant proteins. The relatively large model
substrate was used to overcome the diﬃculties previously found
in visualising inhibition of esterases with PBO analogues.19 In
general, no great improvements were obtained in comparison
with PBO, with just a few analogues performing slightly, but
not signiﬁcantly, better. Analogues with a polyether chain were
more eﬀective than the alkynyl phenoxy equivalents against both
esterase types, with just one alkynyl structure (no. 19, in B-type
analyses) among the ten most potent (Fig. 1A and B).
Whilst for the B-esterase retention of both the MDP moiety and
the polyether chain is preferable for optimum inhibition, with the
Q-type a dihydrobenzofuran moiety is preferred, again with the
polyether chain and an alkyl chain shorter than hexyl. This is in
direct contrast to the M. persicae resistance-associated esterase
(FE4) where it was found that a dihydrobenzofuranmoiety with an
alkynyl side chain conferred optimum inhibition.
The model substrate chosen for the inhibition studies of
CYP6CM1 was 7-EC, due in part to the ﬁndings of Karunker
et al.,40 who examined the metabolic eﬃciency of CYP6CM1vQ
against a number of model P450 ﬂuorescent substrates and found
that 7-EC gave the highest speciﬁc activity (20 pmol min−1 pmol−1
P450).
Results of the preliminary P450 inhibition assays (Table 2) also
found that CYP6CM1 inhibition was not increased considering a
Arg 224
Phe 501
Phe 64
Pro 117
Leu 234
Lys 412
Figure4. In silicomodel of EN1–215 (white) and EN16–41 (yellow) docked
with CYP6CM1. Hydrogen bonds (dotted lines) between EN 1-215/ EN
16–41 and Lys-412 are shown.
10min to 30min incubation; indeed, equal inhibition was found
from all four conditions.
Suicide substrates form a complex with the enzyme, whereupon
the enzyme catalyses the reversible production of a complex
with the activated intermediate, which could then be released
as a product, releasing free enzyme or modify the enzyme. If
the latter, inhibition would be expected to be time dependent.
If the ﬁnal modiﬁcation of the enzyme is relatively slow, the
enzyme: activated intermediate complex can be dissociated by
other substrates. The degree of MDP activation by P450s has also
been reported to be ‘quantitatively unique’ for each P450,42 so it
could be that relatively little activation occurs with CYP6CM1.
Since the research is to ﬁnd a structure that would work well
in the ﬁeld, it was decided that the closest condition to spraying
an insect would be to subject the analogue to both NADPH and
substrate (albeit a model substrate) at the same time, i.e. not to
pre-activate the MDP moieties with NADPH prior to incubation
with substrate.
Similar to the results found both with the M. persicae P450
(CYP6CY3), and with house ﬂy P450 (CYP6D1): removal of the alkyl
chain from the PBO-like structures, resulted in a loss of inhibitory
potency.33,43
In contrast to the M. persicae P450, CYP6CY3, incubation of
CYP6CM1 with PBO did not result in high inhibition at the diag-
nostic concentration, andmany of the alternative analogues actu-
ally resulted in superior inhibition. Indeed, the ‘PBO-like’ structures
containing both an MDP ring and ethoxy chain did not reveal
potent inhibition, which seemed the preserve of those structures
containing an alkynyl chain. The exception was structure 21, but
this contained both ethoxy and alkynyl chains.
Itwas reported that the constitutiveover-expressionofCYP6CM1
gene is correlated to imidacloprid resistance in both B and Q
biotypes.8 Metabolism of imidacloprid was conﬁrmed by LC-MS
and molecular docking and dynamic simulations suggested key
residues responsible for imidacloprid binding and metabolism.40
5 CONCLUSIONS
In this study, although no clear correlations could be detected
between CYP6CM1 and B- or Q-esterases, bi-variate plots high-
lighted structure no. 21 as one of the most potent inhibitors. Pre-
liminary in silico modelling of this analogue suggested a shift in
wileyonlinelibrary.com/journal/ps © 2017 Society of Chemical Industry Pest Manag Sci 2017; 73: 1873–1882
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position when compared with PBO, resulting in hydrogen bonds
being formed with Arg-224 and Phe-501. The former residue was
identiﬁed by Karunker and colleagues40 as a key residue in stabil-
ising imidacloprid binding by aromatic interactions; the presence
of PBO or analogue 21would therefore occupy a space preventing
interactions between CYP6CM1 and imidacloprid, with no. 21 the
more diﬃcult to displace.
The presently used set of analogues was synthesised to inves-
tigate interactions on speciﬁc detoxifying enzymes derived from
resistant samples ofM.persicae33 andonwholehomogenates from
M. persicae and pollen beetle Meligethes aeneus (Fabricius).44 In
these studies some common structural features were identiﬁed as
key elements for the interactionwith the P450 speciﬁcally involved
in insecticide detoxiﬁcation, CYP6CY3 for M. persicae and total
P450 activity from M. aeneus. Thus benzodioxole derivatives con-
taining an alkynyl chain and a propyl or a butyl side chainwere the
most potent inhibitors. Since both CYP6CM1 and CYP6CY3 have
been reported as P450s that have likely evolved to allow colonisa-
tion of cotton by these insect species,45,46 it is perhaps surprising
that they have diﬀerent model substrate preferences and a diﬀer-
ent inhibition matrix to the PBO analogues. However, both insects
aregeneralist feeders, and inevitablywith a limited supply of P450s
available the enzymes will therefore span a multitude of poten-
tially toxic xenobiotics. It is possible that were they both specialist
cotton feeders, the response of the nicotine-metabolising P450s
would be closer.
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